<?xml version="1.0" encoding="utf-8"?>
<root>
  <passage>
    <infon key="section_type">TITLE</infon>
    <text>Low frequency of mutations in the core promoter and precore regions of hepatitis B virus in anti-HBe positive Brazilian carriers</text>
  </passage>
  <passage>
    <infon key="section_type">ABSTRACT</infon>
    <text>The data presented here differs from certain reports in other regions. In half of the isolates, the occurrence of anti-HBe phenotype could not be explained by any of these previously described mutations.</text>
  </passage>
  <passage>
    <infon key="section_type">INTRO</infon>
    <text>Embryonic submandibular gland (SMG) development is best understood as a phase process, not gestational age. Repeated branching at the distal ends of the first epithelial SMG bud produces what appears to be &quot;a bush-like network&quot;â€”a network consisting of elongated epithelial branches that terminate in epitaxmally by the Pseudoglandular Stage and epithelium buds at their termini. Epithelial lobes have been increased in number and the presumptive ducts start to show distinct lumina during the Canalicular Stage. By the Terminal Bud Stage, these branches and buds are hollowed out to form the precursor cells of all stages, giving rise to their formation as branches. Earlier investigations have shown that the Canalicular Stage marks the start of lumen formation, which is initiated by the death of the central cells, with each successive concentric layer of cells dying until only a single epithelial cell survives around the lumina. Apoptosis-mediated p53 directed towards and marking the next concentric layer of epithelial cells that are bound to die is shown to be important in terminal (potential) apoptate formation of the bud lumen, while caspase8/caspaseed3-related is important for ductal lumeN formation. Despite the identification of multiple apoptotic pathways that mediate duct and terminal bud lumen formation, we are unaware of which specific molecules or proteins play cleaving roles in the stop signal process. The survival of these epithelial cells bound by lumends is dependent on programmed cell death, which is essential for maintaining developmental homeostasis and the normal morphogenesis of embryonic tissues. Survivin, a member of the IAP family, is distinguished by its prominent expression in embryonic tissues, overexpressed in cancer cells, and undetectable in normal adult tissues. Gene targeting experiments demonstrate that survivIN plays both roles as elicitor of cellular survival and anti-apoptotic factors. It has been shown that survivin, which is expressed separately in cell cycles, can transfer into the nucleus and bind to Cdk4/p16INK4a during development, as null embryos do not develop normal microtubules, are polyploid, and survive beyond day 4.5. Cdk2/Cyclin E is activated by the Cadd/survivin complex, which facilitates S phase entry. The formation of this complex also triggers the release of p21, leading to the formation and regulation of procaspase 3, which prevents cell death. Based on the information provided above, we hypothesized that survivin is a crucial molecule that promotes survival and prevents cell death during embryonic ductal and proacinar processes. The paper analyzed the developmental expression of survivin transcripts and protein in embryonic SMGs. This is the first time that significant developmental changes in survin expression and localization with embryonal lumen formation have been reported.</text>
  </passage>
  <passage>
    <infon key="section_type">CONCL</infon>
    <text>According to the new findings, clonal expansion is a prevalent feature in the B-cell repertoire of patients with rheumatoid arthritis. This expansion involves resting memory B cells and activated B cell repertoires, some of which are derived from the memory Brain tumor's internal compartment. As the range of clonal expansions increases, from the bloodstream to the synovial compartment, the narrowing of diversity indicates that these antigens located in the brain are responsible for these &quot;antigen-receptor biases,&quot; and evidence suggests that some of these expansion patterns may be joint-specific. Due to the rarity of identical clones in two distinct joints, immune reactions are likely unique to each joint. Additionally, B cells from this joint are unlikely to contain a different foreign antigen, so they are reacting with autoantigens produced locally, potentially by local tissue breakdown. Lymphoid aggregates that contain the cellular components of an ectopic germinal center can be formed in synovial tissue of rheumatoidic arthritis patients, as new research has shown, and can maintain B-cell clonal expansion and diversification. It is likely that the B cells that mature in these 'pseudogerminal centers' and those that we have identified in the current studies are responding to specific (auto)antigens. Hence, the identification of antigenic reactivations of these B cells, and specifically of those within the memory compartment that have probably &quot;passed over (auto)antigen and T cell selection and rescue&quot;; in this case, they may provide important clues about the role of B lymphocytes and their immunoglobulin molecules in the immunopathogenesis of rheumatoid arthritis.</text>
  </passage>
</root>
